You are here: Home » Current Affairs » Coronavirus » News
Business Standard

Pfizer-BioNTech ask EU agency to approve vaccine for kids 5-11

Pharmaceutical company Pfizer and biotechnology company BioNTech said Friday they have requested to have their coronavirus vaccine licensed for children ages 5 to 11 across the European Union

Topics
Coronavirus Vaccine | Pfizer | European Union

AP  |  Berlin 

Pfizer
(Photo: Reuters)

Pharmaceutical company and biotechnology company BioNTech said Friday they have requested to have their licensed for children ages 5 to 11 across the .

If EU regulators agree, it would be the first opportunity for younger children in Europe to get immunized against COVID-19.

and BioNTech said they submitted data to the European Medicines Agency, including late-stage results from a study testing their COVID-19 vaccine in more than 2,200 children ages 6 months to 11 years. The children received a lower dose than what's normally given to adults.

The companies said in a statement that the results showed a strong immune response in the children and that the vaccine was also found to be safe.

There are currently no COVID-19 vaccines licensed for use in children younger than 12 in Europe or North America; the ones made by Pfizer-BioNTech and Moderna are authorized for children 12 and older in the .

Earlier this month, and BioNTech asked the U.S. Food and Drug Administration to greenlight their vaccine for children ages 5 to 11.

Expanding vaccine availability to roughly 28 million more U.S. children was seen as another milestone in the fight against the virus and comes amid an alarming rise in serious infections in youngsters because of the extra-contagious delta variant.

In the United States, COVID-19 has killed at least 520 children so far, according to the American Academy of Pediatrics.

With much of Europe's adult population already immunized, many countries are seeing increasing outbreaks of the disease in children while schools are mostly open and operating with sometimes patchy guidance on mask-wearing and social distancing.

The World Health Organization has said that vaccinating children was not a priority because they are far less likely to develop serious disease or to die of COVID-19. The health agency has repeatedly urged rich countries to share their doses with poor countries instead of expanding domestic eligibility so the world's vulnerable populations can be immunized.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

Dear Reader,


Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.

As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.

Support quality journalism and subscribe to Business Standard.

Digital Editor

First Published: Fri, October 15 2021. 21:39 IST
RECOMMENDED FOR YOU